Form 4 for CAPR CAPRICOR THERAPEUTICS, INC.
Accepted 2024-09-24 00:00:00 ET · period of report 2024-09-20 · accession 0000929638-24-003214 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-24 | 2024-09-20 | CAPR | Nippon Shinyaku Co Ltd | 10% | P - Purchase | $5.36 | +2.80M | 7.09M | +65% | +$15.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.001 per share | 2024-09-20 | P | A | 2,798,507 | $5.36 | 7,090,351 | D | — | — | (F1) On September 20, 2024, Capricor Therapeutics, Inc., a Delaware corporation (the "Issuer") issued 2,798,507 shares of common stock, $0.001 par value per share (the "Common Stock") to Nippon Shinyaku Co Ltd (the "Reporting Person"), acquired in a private placement pursuant to the terms and conditions of a Subscription Agreement, dated as of September 16, 2024, between the Reporting Person and the Issuer. |